PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 15 filers reported holding PHIO PHARMACEUTICALS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 50 | -94.3% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 870 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 870 | -41.9% | 0.00% | – |
| Q1 2022 | $1,000 | – | 1,497 | +300.3% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 374 | -50.4% | 0.00% | – |
| Q3 2021 | $2,000 | -77.8% | 754 | -80.8% | 0.00% | – |
| Q2 2021 | $9,000 | -35.7% | 3,930 | -25.4% | 0.00% | – |
| Q1 2021 | $14,000 | +1300.0% | 5,270 | +2535.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 200 | -99.1% | 0.00% | – |
| Q1 2020 | $38,000 | – | 21,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 154,536 | $57,487 | 0.00% |
| UBS Group AG | 23,029 | $8,521 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 22,398 | $8,332 | 0.00% |
| Cetera Investment Advisers | 75,000 | $27,900 | 0.00% |
| WELLS FARGO & COMPANY/MN | 93 | $35 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 106,917 | $39 | 0.00% |
| MORGAN STANLEY | 1,500 | $558 | 0.00% |
| BlackRock Inc. | 19 | $7 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 19,707 | $7,331 | 0.00% |